Experience of a Single Center in Treating Multiple Manifestations of Tuberous Sclerosis Complex with Everolimus
Purpose The aim of this study was to evaluate the efficacy and tolerability of everolimus, an oral mammalian target of rapamycin (mTOR) inhibitor, for the treatment of tuberous sclerosis complex (TSC) manifestations. Methods A retrospective analysis was conducted using an in-house research database...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Korean Child Neurology Society,
2019-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|